Skip to main content

Torsemide Pregnancy and Breastfeeding Warnings

Brand names: Demadex, Demadex IV, Soaanz

Medically reviewed by Drugs.com. Last updated on Jul 25, 2025.

Torsemide Pregnancy Warnings

Safety has not been established during pregnancy.

US FDA pregnancy category: Not assigned

Risk summary: No data are available on the use of this drug in pregnant women to inform a drug-related risk.

Animal studies revealed evidence of decreases in body weight, decreased fetal absorption and delayed ossification. There are no controlled data in human pregnancy.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

See references

Torsemide Breastfeeding Warnings

UK: Use is contraindicated.
US: Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Unknown

Comments: The effects in the nursing infant are unknown.

See references

Does Torsemide interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

See also

References for pregnancy information

  1. "Product Information. Demadex (torsemide)." Boehringer Mannheim
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics."
  3. (2021) "Product Information. Soaanz (torsemide)." Sarfez Pharmaceuticals, Inc.

References for breastfeeding information

  1. "Product Information. Demadex (torsemide)." Boehringer Mannheim
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics."

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer